2024-03-28T20:15:39Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_1D10623CEEFD
2024-03-23T01:56:31Z
serval:BIB_1D10623CEEFD
Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review.
10.1016/j.radonc.2012.04.002
22560713
000305845000002
Fairchild
A.
author
Weber
D.C.
author
Bar-Deroma
R.
author
Gulyban
A.
author
Fenton
P.A.
author
Stupp
R.
author
Baumert
B.G.
author
article
2012
Radiotherapy and Oncology
1879-0887
0167-8140
journal
103
3
287-292
Antineoplastic Agents, Alkylating/therapeutic use
Brain Neoplasms/drug therapy
Brain Neoplasms/radiotherapy
Combined Modality Therapy
Dacarbazine/analogs & derivatives
Dacarbazine/therapeutic use
Electronic Health Records/standards
Glioma/drug therapy
Glioma/radiotherapy
Humans
Quality Assurance, Health Care
Radiotherapy Dosage
eng
60_published
Publication types: Clinical Trial, Phase III ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov'tPublication Status: ppublish. Quality assurance.